A Study of ASP1893 in Adults With Advanced CLDN6-positive Solid Tumors

Clinical trial NCT06681870 · WITHDRAWN

Trial details

NCT number: NCT06681870
Sponsor: Astellas Pharma Global Development, Inc.
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

CLDN6-positive Solid Tumor Ovarian Cancer Endometrial Cancer Non-small Cell Lung Cancer Testicular Cancer Metastatic or Locally Advanced Solid Tumor Cancer

Start date: 2024-12-31
Primary completion: 2029-03-31
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.